GLP-1 Drugs Emerge as Popular Weight Loss Option

Brown University professor Dr. Emily Oster discusses the impact of GLP-1 medications on weight loss.

Mar. 30, 2026 at 10:20pm

Got story updates? Submit your updates here. ›

A translucent, ghostly X-ray photograph showing the intricate details of the human digestive system, glowing with an ethereal blue-green light and hinting at the complex biological processes involved in weight loss and metabolic regulation.An X-ray view into the inner workings of the human body reveals the complex biological mechanisms behind new weight loss medications.Providence Today

Just a few years ago, the term 'GLP-1' was relatively unknown, but these drugs have now become a popular option for weight loss under various brand names. Dr. Emily Oster, a Brown University professor and CEO of Parent Data, recently joined a local news program to share insights on the effectiveness, side effects, and potential for treating other diseases with GLP-1 medications.

Why it matters

As obesity rates continue to rise, new weight loss treatments like GLP-1 drugs have gained significant attention and interest from both patients and the medical community. Understanding the impact and implications of these medications is crucial for individuals seeking effective weight management solutions.

The details

GLP-1 drugs, or glucagon-like peptide-1 receptor agonists, work by mimicking a hormone that regulates blood sugar levels and appetite. This can lead to reduced calorie intake and increased fat burning, resulting in weight loss for many patients. Dr. Oster discussed the potential side effects of GLP-1 medications, such as nausea and gastrointestinal issues, as well as the possibility of using these drugs to treat other conditions beyond weight loss.

  • GLP-1 drugs have become more widely known and used in the past few years.

The players

Dr. Emily Oster

A Brown University professor and CEO of Parent Data, who provided insights on the impact of GLP-1 drugs for weight loss.

WPRI

A local news station in Providence, Rhode Island, that hosted the interview with Dr. Oster.

Got photos? Submit your photos here. ›

What they’re saying

“Just a few years ago, 'GLP-1' wasn't a commonly known term. Now, it's become a popular drug being marketed for weight loss under different brand names.”

— Dr. Emily Oster, Brown University Professor and CEO of Parent Data

The takeaway

As the medical community continues to explore the potential of GLP-1 drugs for weight loss and other health conditions, understanding the benefits, risks, and implications of these medications will be crucial for individuals seeking effective and safe treatment options.